Elite Pharmaceuticals Inc (ELTP)

[Hike]

Is the ELTP/Precision Dose-Tagi agreement now "complete"? More milestone payments due upon shipment of Naltrexone and Phentermine 15/30. Will Elite look to expand it's agreement with PD/Tagi now?

four (maybe five?) products:
1) Naltrexone 50mg
2) Phentermine 37.5mg
3) Phentermine 15/30mg (count as two products?)
4) Hyromorphone HCL 8mg

http://www.news-medical.net/news/20100917/Elite-Pharmaceuticals-signs-agreements-with-Precision-Dose-for-four-generic-products.aspx

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a license agreement and a manufacturing and supply agreement (together the "Agreements") with Precision Dose, Inc. (Precision Dose) which has a wholly owned subsidiary, TAGI Pharma, Inc. ("TAGI Pharma"), which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products (the "Products") in the United States, Puerto Rico and Canada. Elite will receive a license fee and milestone payments and Elite will manufacture the Products. The license fee will be computed as a percentage of the gross profit, as defined in the License Agreement, earned by TAGI Pharma as a result of sales of the products. The license fee is payable monthly for the term of the License Agreement. The milestone payments will be paid in 6 installments. The first installment was paid upon execution of the License Agreement and the remaining installments are to be paid upon FDA approval and initial shipment of the products to Precision Dose. Two of the Products, hydromorphone hydrochloride, 8 mg, and naltrexone hydrochloride, 50 mg, are approved products recently purchased by Elite and currently being transferred to Elite. Collectively, the brand products and their generic equivalents had total annual sales of approximately $120 million in 2009.